Exploring 1,2,3-triazole-Schiff’s base hybrids as innovative EGFR inhibitors for the treatment of breast cancer: In vitro and in silico study
Nareman A. Nawareg, Asmaa S. A. Yassen, Ebtehal M. Husseiny, Mohamed A. Elsayed, Hosam A. Elshihawy
Topics & Concepts
In silicoChemistryIn vitroBreast cancerTriazoleSchiff baseCancer researchCancerBiochemistryInternal medicineStereochemistryBiologyOrganic chemistryMedicineGeneClick Chemistry and ApplicationsSynthesis and biological activityComputational Drug Discovery Methods